Illustrative image – not actual.Aurobindo Pharma is revamping its production operations with an investment of Rs.75 crore. The project is expected to be complete by December 2001 – January 2002.
Under the project, the company will integrate its existing
six units in Andhra Pradesh and shut down the Pondicherry unit. The company
also plans to set up a new unit at Visakhapatnam with an investment of Rs.30
crore.
The company aims to have two bulk drug units with US
FDA approvals and two large scale and cost efficient bulk drug units with GMP
standards to meet the requirements of emerging markets. Two formulation units
will also be upgraded to get FDA approval.
